Copyright Reports & Markets. All rights reserved.

Europe Cancer Therapeutics and Biotherapeutic Market Report 2018

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Definition and Specification
    • 1.2 Report Overview
      • 1.2.1 Manufacturers Overview
      • 1.2.2 Regions Overview
      • 1.2.3 Type Overview
      • 1.2.4 Application Overview
    • 1.3 Industrial Chain
      • 1.3.1 Cancer Therapeutics and Biotherapeutic Overall Industrial Chain
      • 1.3.2 Upstream
      • 1.3.3 Downstream
    • 1.4 Industry Situation
      • 1.4.1 Industrial Policy
      • 1.4.2 Product Preference
      • 1.4.3 Economic/Political Environment
    • 1.5 SWOT Analysis

    2 Market Analysis by Types

    • 2.1 Overall Market Performance(Volume)
      • 2.1.1 Chemotherapy Market Performance (Volume)
      • 2.1.2 Radiation Therapy Market Performance (Volume)
      • 2.1.3 Hormone Therapy Market Performance (Volume)
      • 2.1.4 Biotherapy Market Performance (Volume)
      • 2.1.5 Others Market Performance (Volume)
    • 2.2 Overall Market Performance(Value)
      • 2.1.1 Chemotherapy Market Performance (Value)
      • 2.1.2 Radiation Therapy Market Performance (Value)
      • 2.1.3 Hormone Therapy Market Performance (Value)
      • 2.1.4 Biotherapy Market Performance (Value)
      • 2.1.5 Others Market Performance (Value)

    3 Product Application Market

    • 3.1 Overall Market Performance (Volume)
      • 3.1.1 Application 1 Market Performance (Volume)
      • 3.1.2 Application 2 Market Performance (Volume)

    4 Manufacturers Profiles/Analysis

    • 4.1 Astra Zeneca PLC
      • 4.1.1 Astra Zeneca PLC Profiles
      • 4.1.2 Astra Zeneca PLC Product Information
      • 4.1.3 Astra Zeneca PLC Cancer Therapeutics and Biotherapeutic Business Performance
      • 4.1.4 Astra Zeneca PLC Cancer Therapeutics and Biotherapeutic Business Development and Market Status
    • 4.2 Biogen IDEC
      • 4.2.1 Biogen IDEC Profiles
      • 4.2.2 Biogen IDEC Product Information
      • 4.2.3 Biogen IDEC Cancer Therapeutics and Biotherapeutic Business Performance
      • 4.2.4 Biogen IDEC Cancer Therapeutics and Biotherapeutic Business Development and Market Status
    • 4.3 Bristol-Myers Squibb
      • 4.3.1 Bristol-Myers Squibb Profiles
      • 4.3.2 Bristol-Myers Squibb Product Information
      • 4.3.3 Bristol-Myers Squibb Cancer Therapeutics and Biotherapeutic Business Performance
      • 4.3.4 Bristol-Myers Squibb Cancer Therapeutics and Biotherapeutic Business Development and Market Status
    • 4.4 Sanofi
      • 4.4.1 Sanofi Profiles
      • 4.4.2 Sanofi Product Information
      • 4.4.3 Sanofi Cancer Therapeutics and Biotherapeutic Business Performance
      • 4.4.4 Sanofi Cancer Therapeutics and Biotherapeutic Business Development and Market Status
    • 4.5 Merck
      • 4.5.1 Merck Profiles
      • 4.5.2 Merck Product Information
      • 4.5.3 Merck Cancer Therapeutics and Biotherapeutic Business Performance
      • 4.5.4 Merck Cancer Therapeutics and Biotherapeutic Business Development and Market Status
    • 4.6 Johnson & Johnson
      • 4.6.1 Johnson & Johnson Profiles
      • 4.6.2 Johnson & Johnson Product Information
      • 4.6.3 Johnson & Johnson Cancer Therapeutics and Biotherapeutic Business Performance
      • 4.6.4 Johnson & Johnson Cancer Therapeutics and Biotherapeutic Business Development and Market Status
    • 4.7 Schering-Plough
      • 4.7.1 Schering-Plough Profiles
      • 4.7.2 Schering-Plough Product Information
      • 4.7.3 Schering-Plough Cancer Therapeutics and Biotherapeutic Business Performance
      • 4.7.4 Schering-Plough Cancer Therapeutics and Biotherapeutic Business Development and Market Status
    • 4.8 Roche
      • 4.8.1 Roche Profiles
      • 4.8.2 Roche Product Information
      • 4.8.3 Roche Cancer Therapeutics and Biotherapeutic Business Performance
      • 4.8.4 Roche Cancer Therapeutics and Biotherapeutic Business Development and Market Status

    5 Market Performance for Manufacturers

    • 5.1 Europe Cancer Therapeutics and Biotherapeutic Sales (K Units) and Market Share by Manufacturers 2013-2018
    • 5.2 Europe Cancer Therapeutics and Biotherapeutic Revenue (M USD) and Market Share by Manufacturers 2013-2018
    • 5.3 Europe Cancer Therapeutics and Biotherapeutic Price (USD/Unit) of Manufacturers 2013-2018
    • 5.4 Europe Cancer Therapeutics and Biotherapeutic Gross Margin of Manufacturers 2013-2018
    • 5.5 Market Concentration

    6 Regions Market Performance for Manufacturers

    • 6.1 Germany Market Performance for Manufacturers
      • 6.1.1 Germany Cancer Therapeutics and Biotherapeutic Sales (K Units) and Share of Manufacturers 2013-2018
      • 6.1.2 Germany Cancer Therapeutics and Biotherapeutic Revenue (M USD) and Share of Manufacturers 2013-2018
      • 6.1.3 Germany Cancer Therapeutics and Biotherapeutic Price (USD/Unit) of Manufacturers 2013-2018
      • 6.1.4 Germany Cancer Therapeutics and Biotherapeutic Gross Margin of Manufacturers 2013-2018
      • 6.1.5 Market Concentration
    • 6.2 UK Market Performance for Manufacturers
      • 6.2.1 UK Cancer Therapeutics and Biotherapeutic Sales (K Units) and Share of Manufacturers 2013-2018
      • 6.2.2 UK Cancer Therapeutics and Biotherapeutic Revenue (M USD) and Share of Manufacturers 2013-2018
      • 6.2.3 UK Cancer Therapeutics and Biotherapeutic Price (USD/Unit) of Manufacturers 2013-2018
      • 6.2.4 UK Cancer Therapeutics and Biotherapeutic Gross Margin of Manufacturers 2013-2018
      • 6.2.5 Market Concentration
    • 6.3 France Market Performance for Manufacturers
      • 6.3.1 France Cancer Therapeutics and Biotherapeutic Sales (K Units) and Share of Manufacturers 2013-2018
      • 6.3.2 France Cancer Therapeutics and Biotherapeutic Revenue (M USD) and Share of Manufacturers 2013-2018
      • 6.3.3 France Cancer Therapeutics and Biotherapeutic Price (USD/Unit) of Manufacturers 2013-2018
      • 6.3.4 France Cancer Therapeutics and Biotherapeutic Gross Margin of Manufacturers 2013-2018
      • 6.3.5 Market Concentration
    • 6.4 Russia Market Performance for Manufacturers
      • 6.4.1 Russia Cancer Therapeutics and Biotherapeutic Sales (K Units) and Share of Manufacturers 2013-2018
      • 6.4.2 Russia Cancer Therapeutics and Biotherapeutic Revenue (M USD) and Share of Manufacturers 2013-2018
      • 6.4.3 Russia Cancer Therapeutics and Biotherapeutic Price (USD/Unit) of Manufacturers 2013-2018
      • 6.4.4 Russia Cancer Therapeutics and Biotherapeutic Gross Margin of Manufacturers 2013-2018
      • 6.4.5 Market Concentration
    • 6.5 Benelux Market Performance for Manufacturers
      • 6.5.1 Benelux Cancer Therapeutics and Biotherapeutic Sales (K Units) and Share of Manufacturers 2013-2018
      • 6.5.2 Benelux Cancer Therapeutics and Biotherapeutic Revenue (M USD) and Share of Manufacturers 2013-2018
      • 6.5.3 Benelux Cancer Therapeutics and Biotherapeutic Price (USD/Unit) of Manufacturers 2013-2018
      • 6.5.4 Benelux Cancer Therapeutics and Biotherapeutic Gross Margin of Manufacturers 2013-2018
      • 6.5.5 Market Concentration
    • 6.6 Italy Market Performance for Manufacturers
      • 6.6.1 Italy Cancer Therapeutics and Biotherapeutic Sales (K Units) and Share of Manufacturers 2013-2018
      • 6.6.2 Italy Cancer Therapeutics and Biotherapeutic Revenue (M USD) and Share of Manufacturers 2013-2018
      • 6.6.3 Italy Cancer Therapeutics and Biotherapeutic Price (USD/Unit) of Manufacturers 2013-2018
      • 6.6.4 Italy Cancer Therapeutics and Biotherapeutic Gross Margin of Manufacturers 2013-2018
      • 6.6.5 Market Concentration
    • 6.7 Spain Market Performance for Manufacturers
      • 6.7.1 Spain Cancer Therapeutics and Biotherapeutic Sales (K Units) and Share of Manufacturers 2013-2018
      • 6.7.2 Spain Cancer Therapeutics and Biotherapeutic Revenue (M USD) and Share of Manufacturers 2013-2018
      • 6.7.3 Spain Cancer Therapeutics and Biotherapeutic Price (USD/Unit) of Manufacturers 2013-2018
      • 6.7.4 Spain Cancer Therapeutics and Biotherapeutic Gross Margin of Manufacturers 2013-2018
      • 6.7.5 Market Concentration
    • 6.8 Market Performance for Manufacturers
      • 6.8.1 Cancer Therapeutics and Biotherapeutic Sales (K Units) and Share of Manufacturers 2013-2018
      • 6.8.2 Cancer Therapeutics and Biotherapeutic Revenue (M USD) and Share of Manufacturers 2013-2018
      • 6.8.3 Cancer Therapeutics and Biotherapeutic Price (USD/Unit) of Manufacturers 2013-2018
      • 6.8.4 Cancer Therapeutics and Biotherapeutic Gross Margin of Manufacturers 2013-2018
      • 6.8.5 Market Concentration

    7 Europe Cancer Therapeutics and Biotherapeutic Market Performance (Sales Point)

    • 7.1 Europe Cancer Therapeutics and Biotherapeutic Sales (K Units) and Market Share by Regions 2013-2018
    • 7.2 Europe Cancer Therapeutics and Biotherapeutic Revenue (M USD) and Market Share by Regions 2013-2018
    • 7.3 Europe Cancer Therapeutics and Biotherapeutic Price (USD/Unit) by Regions 2013-2018
    • 7.4 Europe Cancer Therapeutics and Biotherapeutic Gross Margin by Regions 2013-2018

    8 Development Trend for Regions (Sales Point)

    • 8.1 Europe Cancer Therapeutics and Biotherapeutic Sales and Growth, Sales Value and Growth Rate2013-2018
    • 8.2 Germany Cancer Therapeutics and Biotherapeutic Sales and Growth, Sales Value and Growth Rate2013-2018
    • 8.3 UK Cancer Therapeutics and Biotherapeutic Sales and Growth, Sales Value and Growth Rate2013-2018
    • 8.4 France Cancer Therapeutics and Biotherapeutic Sales and Growth, Sales Value and Growth Rate2013-2018
    • 8.5 Russia Cancer Therapeutics and Biotherapeutic Sales and Growth, Sales Value and Growth Rate2013-2018
    • 8.6 Benelux Cancer Therapeutics and Biotherapeutic Sales and Growth, Sales Value and Growth Rate2013-2018
    • 8.7 Italy Cancer Therapeutics and Biotherapeutic Sales and Growth, Sales Value and Growth Rate2013-2018
    • 8.8 Spain Cancer Therapeutics and Biotherapeutic Sales and Growth, Sales Value and Growth Rate2013-2018
    • 8.8 Spain Cancer Therapeutics and Biotherapeutic Sales and Growth, Sales Value and Growth Rate2013-2018

    9 Upstream Source, Technology and Cost

    • 9.1 Upstream Source
    • 9.2 Technology
    • 9.3 Cost

    10 Channel Analysis

    • 10.1 Market Channel
    • 10.2 Distributors

    11 Consumer Analysis

    • 11.1 Application 1 Industry
    • 11.2 Application 2 Industry

    12 Market Forecast 2019-2024

    • 12.1 Sales (K Units), Revenue (M USD), Market Share and Growth Rate 2019-2024
      • 12.1.1 Europe Cancer Therapeutics and Biotherapeutic Sales (K Units), Revenue (M USD) and Market Share by Regions 2019-2024
      • 12.1.2 Europe Cancer Therapeutics and Biotherapeutic Sales (K Units) and Growth Rate 2019-2024
      • 12.1.3 Germany Cancer Therapeutics and Biotherapeutic Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 12.1.4 UK Cancer Therapeutics and Biotherapeutic Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 12.1.5 France Cancer Therapeutics and Biotherapeutic Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 12.1.6 Russia Cancer Therapeutics and Biotherapeutic Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 12.1.7 Benelux Cancer Therapeutics and Biotherapeutic Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 12.1.8 Italy Cancer Therapeutics and Biotherapeutic Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 12.1.9 Spain Cancer Therapeutics and Biotherapeutic Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
    • 12.3 Sales (K Units), Revenue (M USD) by Types 2019-2024
      • 12.3.1 Overall Market Performance
      • 12.3.2 Chemotherapy Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 12.3.3 Radiation Therapy Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 12.3.4 Hormone Therapy Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 12.3.5 Biotherapy Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
    • 12.4 Sales by Application 2019-2024
      • 12.4.1 Overall Market Performance
      • 12.4.2 Application 1 Sales and and Growth Rate 2019-2024
      • 12.4.3 Application 2 Sales and and Growth Rate 2019-2024
    • 12.5 Price (USD/Unit) and Gross Profit
      • 12.5.1 Europe Cancer Therapeutics and Biotherapeutic Price (USD/Unit) Trend 2019-2024
      • 12.5.2 Europe Cancer Therapeutics and Biotherapeutic Gross Profit Trend 2019-2024

    13 Conclusion

    Geographically, this report split Europe into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Cancer Therapeutics and Biotherapeutic for these regions, from 2012 to 2023 (forecast), including
    Germany
    UK
    France
    Russia
    Benelux
    Italy
    Spain

    Europe Cancer Therapeutics and Biotherapeutic market competition by top manufacturers/players, with Cancer Therapeutics and Biotherapeutic sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
    Astra Zeneca PLC
    Biogen IDEC
    Bristol-Myers Squibb
    Sanofi
    Merck
    Johnson & Johnson
    Schering-Plough
    Roche

    On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into
    Chemotherapy
    Radiation Therapy
    Hormone Therapy
    Biotherapy
    Others

    On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Units), market share and growth rate of Cancer Therapeutics and Biotherapeutic for each application, including
    Application 1
    Application 2

    If you have any special requirements, please let us know and we will offer you the report as you want.

    Buy now